PNPT1 Knockout A-549 Cell Line
Cat.No.:
EDC07710
Species:
Human
Cell Name:
A-549
Gene:
PNPT1
Gene ID:
87178
Size:
1×10⁶cells
PNPT1 Knockout A549 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07710 |
|---|---|
| Product Name | PNPT1 Knockout A549 Cell Line |
| Species | Human |
| Cell Line | A-549 |
| Cellosaurus ID | CVCL_0023 |
| Gene ID | |
| Cell Line Synonyms | A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549 |
| Gene | PNPT1 |
| Summary |
The protein encoded by this gene belongs to the evolutionary conserved polynucleotide phosphorylase family comprised of phosphate dependent 3'-to-5' exoribonucleases implicated in RNA processing and degradation. This enzyme is predominantly localized in the mitochondrial intermembrane space and is involved in import of RNA to mitochondria. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency-13 and autosomal recessive nonsyndromic deafness-70. Related pseudogenes are found on chromosomes 3 and 7. [provided by RefSeq, Dec 2012]
|
| Digestion Time | 4~5 min |
| Associated Diseases | Non-Small Cell Lung Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1:4~1:5 |
| Complete Culture Medium | F-12K+10% FBS |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: A-549 | STR Info (Cell bank) Cell Line: A-549 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | Y | X | Y |
| CSF1PO | 10 | 12 | 10 | 12 |
| D2S1338 | 24 | 24 | ||
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 11 | ||
| D7S820 | 8 | 11 | 8 | 11 |
| D8S1179 | 13 | 14 | 13 | 14 |
| D13S317 | 11 | 11 | ||
| D16S539 | 11 | 12 | 11 | 12 |
| D18S51 | 14 | 17 | 14 | 17 |
| D19S433 | 13 | 13 | ||
| D21S11 | 29 | 29 | ||
| FGA | 23 | 23 | ||
| Penta D | 9 | 9 | ||
| Penta E | 7 | 11 | 7 | 11 |
| TH01 | 8 | 9.3 | 8 | 9.3 |
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 14 | 14 | ||
| D6S1043 | 11 | 13 | ||
| D12S391 | 18 | 18 | ||
| D2S441 | 10 | 13 | 10 | 13 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying PNPT1 function, PNPT1 Knockout A-549 Cell Line or PNPT1 overexpression A-549 Cell Line?
The choice depends on whether you are studying PNPT1 (PNPase, polynucleotide phosphorylase)'s role in mitochondrial RNA degradation and small RNA import or modeling mitochondrial diseases. The Knockout line is the standard tool for asking whether PNPase is required for mtRNA quality control — PNPT1 is the principal mitochondrial 3'-5' exoribonuclease, processing mt-RNA precursors and degrading aberrant mtRNAs in the intermembrane space. Overexpression is useful for studying PNPase functions or for testing disease-associated mutations.
For mitochondrial disease research, the EDITGENE PNPT1 Knockout in A-549 enables study of mitochondrial RNA biology — PNPT1 mutations cause autosomal recessive sensorineural deafness type 70 and combined oxidative phosphorylation deficiency 13, with severe mitochondrial dysfunction. Rescue with wild-type or patient-derived mutant PNPT1 enables disease genotype-function studies. The knockout is valuable for studying mitochondrial RNA quality control mechanisms.
What are the application scenarios for this model?
Primary applications:
• Mitochondrial RNA stability: mt-RNA precursor accumulation and mt-mRNA half-life analysis given PNPase's role in mtRNA processing.
• Mitochondrial bioenergetics: Seahorse OCR and mitochondrial respiration analysis given PNPase loss-induced mitochondrial dysfunction.
• Combined oxidative phosphorylation deficiency modeling: rescue with patient-derived PNPT1 mutations for genotype-function studies of mitochondrial disease.
• Small RNA import: mitochondrial small RNA (5S rRNA, RNase P RNA, MRP RNA) import studies given PNPase's reported role.
EDITGENE recommends this model for researchers investigating mitochondrial RNA biology, PNPT1-related mitochondrial diseases, and combined oxidative phosphorylation deficiency mechanisms.
Is this PNPT1 Knockout A-549 Cell Line compatible with overexpression rescue experiments?
Yes. PNPase rescue experiments require attention to mitochondrial targeting and trimerization:
• Construct design: use a codon-modified PNPT1 sequence with a small C-terminal tag (FLAG, HA). PNPT1 has N-terminal mitochondrial targeting sequence — N-terminal tags must not disrupt import.
• Trimerization: PNPase functions as a homotrimer in the mitochondrial intermembrane space — preserve trimerization-relevant regions.
• Disease mutation rescue: patient-derived PNPT1 mutations (e.g., Q387R, E475G, Q481P) enable genotype-function studies of combined oxidative phosphorylation deficiency.
• Functional readout: rescue should restore mt-RNA quality control, mitochondrial respiration, and mt-mRNA processing.
A-549 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download